Home › Asset managers › Compare 2024-2025 › Dimensional vs Lincoln Financial
Dimensional 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 78,417 | 73,148 | 1,211 | 4,058 | 98.4% | 96.6% |
| Board proposals | 65,405 | 60,940 | 1,069 | 3,396 | 98.3% | 96.5% |
| E&S shareholder proposals | 255 | 125 | 0 | 130 | 100.0% | 87.4% |
| Other items | 12,757 | 12,083 | 142 | 532 | 98.8% | 97.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,465 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Dimensional | Lincoln Financial |
|---|---|---|---|---|---|---|
| COLOPLAST A/S | December 5, 2024 | Reelect Niels Peter Louis-Hansen as Director Director Elections |
Board | For | ABSTAIN 8 funds |
FOR 1 fund |
| COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO SABESP | April 29, 2025 | Approve Restricted Stock Plan Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| COMPANY FOR COOPERATIVE INSURANCE | May 27, 2025 | Authorize Share Repurchase Program Up to 199,862 Shares to be Allocated for Employees Stock Incentive program and Authorize Board to Execute All Related Matters Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Loretta J. Feehan Director Elections |
Board | For | WITHHOLD 16 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Michael S. Simmons Director Elections |
Board | For | WITHHOLD 16 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Scott C. James Director Elections |
Board | For | WITHHOLD 16 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Terri L. Herrington Director Elections |
Board | For | WITHHOLD 16 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Thomas E. Barry Director Elections |
Board | For | WITHHOLD 16 funds |
FOR 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Say-on-Pay, nonbinding advisory vote approving executive compensation. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: Brian J. Rayhill Director Elections |
Board | For | FOR 21 funds |
WITHHOLD 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: Gregory S. Washer Director Elections |
Board | For | FOR 21 funds |
WITHHOLD 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: William W. Grounds Director Elections |
Board | For | WITHHOLD 21 funds |
FOR 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | To approve an advisory resolution on executive compensation. Say-on-Pay |
Board | For | AGAINST 22 funds |
FOR 1 fund |
| CONTANGO ORE INC. | June 10, 2025 | To conduct a non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CORE MOLDING TECHNOLOGIES INC. | May 15, 2025 | Election of Directors: Sandra L. Kowaleski Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 1 fund |
| CORE SCIENTIFIC INC. | May 23, 2025 | Election of Directors: Class 1: Adam Sullivan Director Elections |
Board | For | WITHHOLD 10 funds |
FOR 1 fund |
| COSCO SHIPPING DEVELOPMENT CO. LTD. | October 24, 2024 | Approve Proposed Amendments to Corporate Bonds Issuance Plan Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Amount and Use of Proceeds Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Arrangement Relating to the Accumulated Profit Prior to the Issuance Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Authorization by the General Meeting to the Board and Its Authorized Person(s) to Proceed with Relevant Matters in Respect of the Issuance of Shares to Specific Target Subscribers by the Company in their Sole Discretion Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Class and Par Value of Shares to be Issued Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers and Remedial Measures Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Discussion and Analysis Report on the Proposal of the Issuance of A Shares to Specific Investor Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Feasibility Analysis Report on the Use of Proceeds from the Proposed Issuance of A Shares to Specific Target Subscribers by the Company Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Lock-Up Period Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Method and Time of Issuance Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Number of Shares to be Issued Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Place of Listing Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Preliminary Proposal of the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Pricing Benchmark Date, Issue Price and Pricing Principle Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Report on Use of Proceeds from Previous Fund-Raising Activities of the Company Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Satisfaction of the Company of the Requirements for the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Specific Mandate Related to the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Target Subscribers and Method of Subscription Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Undertakings to be Made by the Relevant Entities in Respect of the Measures on the Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Validity Period of the Resolution Prior to the Issuance Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Ashish Arora Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Billie Williamson Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Melissa Reiff Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.c Re-election of Maria Fardis, Ph.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.e Re-election of Simeon J. George, M.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.g Re-election of Katherine A. High, M.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.h Re-election of Sandesh Mahatme, LL.M. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.i Re-election of Christian Rommel, Ph.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.j Re-election of Douglas A. Treco, Ph.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.k Election of Briggs W. Morrison, M.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 5.d Election of Briggs W. Morrison, M.D. Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CVRX INC. | June 3, 2025 | Election of Class I Directors: Mitch Hill Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: Allison M. Leopold Tilley Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: Philip Gregory Calhoun Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DANSKE BANK A/S | March 20, 2025 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 13 funds |
FOR 1 fund |
| DANSKE BANK A/S | March 20, 2025 | Reelect Martin Norkjaer Larsen as Director Director Elections |
Board | For | FOR 13 funds |
ABSTAIN 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | March 25, 2025 | Approve Centralized Registration of Non-Financial Corporate Debt Financing Instruments and Shelf Offering of Corporate Bonds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DEMANT A/S | March 6, 2025 | APPROVE REMUNERATION REPORT (ADVISORY VOTE) Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Angela Titzrath to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Astrid Stange to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Erich Clementi to the Supervisory Board Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DIANTHUS THERAPEUTICS INC. | May 22, 2025 | To approve, on an advisory basis, the compensation paid to our named executive officers; and Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DIANTHUS THERAPEUTICS INC. | May 22, 2025 | To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino Garcia Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DIVERSIFIED HEALTHCARE TRUST | May 29, 2025 | Election of Trustees: Nominees (for Independent Trustee): Lisa Harris Jones Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| DIVERSIFIED HEALTHCARE TRUST | May 29, 2025 | Election of Trustees: Nominees (for Managing Trustee): Adam Portnoy Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
← Previous Page 3 of 45 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.